Active Pharmaceutical Ingredients and Intermediates

We provide customized chemical synthesis for active pharmaceutical ingredients from concept to commercial supply. We are an industry-leading integrated development and manufacturing service provider for small molecule drug substances and their intermediates. Chemistry is core to us. Our track record in producing API and intermediates extends back to the genesis of contract development and manufacturing. Thousands of compounds have been successfully developed and progressed by our R&D, process development and manufacturing teams. Many of these molecules have been scaled under accelerated timelines to meet program objectives. We have an established history and ongoing service programs with the full range of customers from virtual companies to big pharma. Our development and manufacturing services for APIs routinely support: drug substances requiring advanced synthesis expertise and process developmentlate phase clinical programs requiring the scale and expertise provided by Lonza for rapid API commercializationhighly potent compounds requiring our specialized infrastructure and handling capabilitiesADC payloads with the option of integrated services inclusive of monoclonal antibodies, inkers and conjugation services. Phase-appropriate assets support all phases of drug substance development and supply.